In episode #027 I try to respond in real time to the crisis at OpenAI, and question how big of a crisis it really is? Hostile takeovers are part and parcel of any industry driven by innovation and there are some striking parallels between Big Tech and Big Pharma. How should graduates respond in such a job market when The Chaos is the Point?

Chapters:

(0:00) Introduction

(1:42) OpenAI staff's revolution

(5:11) Sam Altman's triumphant return?

(6:37) Microsoft's history of mergers and acquisitions

(8:47) Big Pharma uses the same playbook

(11:14) Pfizer buys cancer drug company Seagen

(14:31) How graduates should respond to workplace chaos.

(15:37) Should you be "Open to work" on LinkedIn?

(18:17) It pays a lot less to switch jobs right now

Show notes:

OpenAI’s open revolt

OpenAI’s CEO hired by Microsoft

Microsoft’s Acquisitions

Big Pharma M&A

Pfizer wins antitrust go-ahead for $43billion acquisition of Seagen

Seagen’s anti-cancer drug pipeline

Open to work on LinkedIn is a red flag

Pays less to switch jobs right now

Thanks for reading BioLab Collective with Jack Wang! Subscribe for free to receive new posts and support my work.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit biolabcollective.substack.com